When Donald Trump descended a golden escalator at Trump Tower in New York City in 2015 to announce the launch of his first ...

The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

US President Donald Trump mentioned the possibility of potential tariffs on foreign-made pharmaceuticals. This threat was ...

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

Companies are developing myostatin inhibitors for GLP-1RA-related muscle loss, but some experts question their necessity.

Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s ...